Marzena Pazgier Selected Research

Tumor Suppressor Protein p53

9/2021	Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression.
2/2019	Dithiocarbamate-inspired side chain stapling chemistry for peptide drug design.
8/2010	D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms.
4/2010	Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marzena Pazgier Research Topics

Disease

20	Infections 02/2022 - 01/2007
7	Neoplasms (Cancer) 09/2021 - 09/2008
5	COVID-19 07/2022 - 01/2021
3	HIV Infections (HIV Infection) 01/2020 - 01/2016
3	Viremia 12/2019 - 09/2015
1	Disease Progression 01/2020
1	Virus Diseases (Viral Diseases) 12/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2019
1	Reinfection 11/2019
1	Bacillary Dysentery (Shigellosis) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Sepsis (Septicemia) 01/2013
1	Glioblastoma (Glioblastoma Multiforme) 08/2010
1	Crohn Disease (Crohn's Disease) 08/2009
1	Inflammation (Inflammations) 01/2007

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 10/2021 - 01/2013
9	VaccinesIBA 04/2021 - 09/2015
7	EpitopesIBA 10/2021 - 01/2016
6	Neutralizing AntibodiesIBA 01/2022 - 01/2017
4	Glycoproteins (Glycoprotein)IBA 07/2022 - 01/2016
4	Peptides (Polypeptides)IBA 09/2021 - 08/2010
4	Tumor Suppressor Protein p53IBA 09/2021 - 04/2010
4	DefensinsIBA 01/2018 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 07/2007 - 01/2007
2	Pharmaceutical PreparationsIBA 07/2022 - 04/2010
2	1- (3- (2- hydroxyl- 3- piperidin- 1- yl- propoxy)- phenoxy)- 3- piperidin- 1- ylpropan- 2- olIBA 07/2022 - 02/2022
2	Antiviral Agents (Antivirals)IBA 01/2019 - 02/2016
2	Oncogene Proteins (Oncogene Protein)IBA 07/2012 - 08/2010
1	AIDSVAXIBA 01/2020
1	AntigensIBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	Viral ProteinsIBA 01/2017
1	Broadly Neutralizing AntibodiesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 02/2016
1	Fc Receptors (Fc Receptor)IBA 09/2015
1	human neutrophil peptide 1IBA 01/2013
1	BAS00127538IBA 01/2013
1	Muramic Acids (Muramic Acid)IBA 01/2013
1	muramyl- NAc- (pentapeptide)pyrophosphoryl- undecaprenolIBA 01/2013
1	Liposomes (Liposome)IBA 08/2010
1	Antineoplastic Agents (Antineoplastics)IBA 08/2010
1	IntegrinsIBA 08/2010
1	cyclic arginine-glycine-aspartic acid peptideIBA 08/2010
1	Histidine (L-Histidine)FDA Link 08/2009
1	Arginine (L-Arginine)FDA Link 08/2009
1	SurvivinIBA 09/2008
1	alpha-DefensinsIBA 08/2008
1	Amino Acids FDA Link 01/2007

Therapy/Procedure

6	Therapeutics 07/2022 - 03/2009
2	Immunotherapy 07/2022 - 02/2022
1	Molecular Targeted Therapy 08/2010